Have we reached the turning point?, page-14

What's going to turn this company around though? It's sperm technology is its only product, and it's no holy grail. It seems to be a long way from making money off it.

A bit too much hoping going on here. 90% of company directors have a lot of "skin in the game." Nusep is no different, and doesn't mean anything in terms of the company's success. That shouldn't be a feature of the company's future.

It's a bio company, so it won't take much to quickly build hype, but where will this hype come from? I think, traders are going to struggle, rightly or wrongly, to get on board considering Nuseps track record.